Pharma & Healthcare
Global Eosinophilic Esophagitis Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307070
- Pages: 152
- Figures: 151
- Views: 2
In 2024, the global market size of Eosinophilic Esophagitis Drug was estimated to be worth US$ 144 million and is forecast to reach approximately US$ 209 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eosinophilic Esophagitis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eosinophilic Esophagitis Drug.
The Eosinophilic Esophagitis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eosinophilic Esophagitis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eosinophilic Esophagitis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
Segment by Type
Budesonide
Fluticasone
Others
Segment by Application
Hospitals
Clinics
Drugstore
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Eosinophilic Esophagitis Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Eosinophilic Esophagitis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eosinophilic Esophagitis Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eosinophilic Esophagitis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eosinophilic Esophagitis Drug.
The Eosinophilic Esophagitis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eosinophilic Esophagitis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eosinophilic Esophagitis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
Segment by Type
Budesonide
Fluticasone
Others
Segment by Application
Hospitals
Clinics
Drugstore
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Eosinophilic Esophagitis Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Eosinophilic Esophagitis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eosinophilic Esophagitis Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Eosinophilic Esophagitis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Market by Application
1.3.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Eosinophilic Esophagitis Drug Market Size Estimates and Forecasts
2.1.1 Global Eosinophilic Esophagitis Drug Revenue 2020-2031
2.1.2 Global Eosinophilic Esophagitis Drug Sales 2020-2031
2.2 Eosinophilic Esophagitis Drug Market Size by Region: 2024 Versus 2031
2.3 Eosinophilic Esophagitis Drug Sales by Region (2020-2031)
2.3.1 Global Eosinophilic Esophagitis Drug Sales by Region: 2020-2025
2.3.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2031)
2.4 Eosinophilic Esophagitis Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Eosinophilic Esophagitis Drug Revenue by Region: 2020-2025
2.4.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020-2031)
3.1.1.1 Global Eosinophilic Esophagitis Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2031)
3.1.2.1 Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2031)
3.1.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2020-2031)
3.1.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Eosinophilic Esophagitis Drug Sales by Application (2020-2031)
3.2.1.1 Global Eosinophilic Esophagitis Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2031)
3.2.2.1 Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2031)
3.2.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2020-2031)
3.2.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Budesonide of Eosinophilic Esophagitis Drug Revenue Market Share by Application
3.3.2 Fluticasone of Eosinophilic Esophagitis Drug Revenue Market Share by Application
3.3.3 Others of Eosinophilic Esophagitis Drug Revenue Market Share by Application
4 Global Eosinophilic Esophagitis Drug by Manufacturers
4.1 Global Top Eosinophilic Esophagitis Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Eosinophilic Esophagitis Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Eosinophilic Esophagitis Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Eosinophilic Esophagitis Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Product Type
4.5.1 Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
4.5.3 Manufacturers Eosinophilic Esophagitis Drug Product Type and Application
4.5.4 Budesonide Market Sales of Eosinophilic Esophagitis Drug by Manufacturer
4.5.5 Fluticasone Market Sales of Eosinophilic Esophagitis Drug by Manufacturer
4.5.6 Others Market Sales of Eosinophilic Esophagitis Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
5.1.4 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Eosinophilic Esophagitis Drug Sales by Product in 2024
5.1.6 AstraZeneca Eosinophilic Esophagitis Drug Sales by Application in 2024
5.1.7 AstraZeneca Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Eosinophilic Esophagitis Drug Products Offered
5.2.4 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Eosinophilic Esophagitis Drug Sales by Product in 2024
5.2.6 GSK Eosinophilic Esophagitis Drug Sales by Application in 2024
5.2.7 GSK Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Bayer
5.3.1 Bayer Company Information
5.3.2 Bayer Description, Business Overview
5.3.3 Bayer Eosinophilic Esophagitis Drug Products Offered
5.3.4 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bayer Eosinophilic Esophagitis Drug Sales by Product in 2024
5.3.6 Bayer Eosinophilic Esophagitis Drug Sales by Application in 2024
5.3.7 Bayer Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.3.8 Bayer Recent Developments
5.4 Adare Pharmaceuticals
5.4.1 Adare Pharmaceuticals Company Information
5.4.2 Adare Pharmaceuticals Description, Business Overview
5.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
5.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales by Product in 2024
5.4.6 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales by Application in 2024
5.4.7 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.4.8 Adare Pharmaceuticals Recent Developments
5.5 DBV Technologies
5.5.1 DBV Technologies Company Information
5.5.2 DBV Technologies Description, Business Overview
5.5.3 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
5.5.4 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 DBV Technologies Eosinophilic Esophagitis Drug Sales by Product in 2024
5.5.6 DBV Technologies Eosinophilic Esophagitis Drug Sales by Application in 2024
5.5.7 DBV Technologies Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.5.8 DBV Technologies Recent Developments
5.6 Dr. Falk Pharma
5.6.1 Dr. Falk Pharma Company Information
5.6.2 Dr. Falk Pharma Description, Business Overview
5.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
5.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales by Product in 2024
5.6.6 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales by Application in 2024
5.6.7 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.6.8 Dr. Falk Pharma Recent Developments
5.7 Quorum Innovations
5.7.1 Quorum Innovations Company Information
5.7.2 Quorum Innovations Description, Business Overview
5.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
5.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Quorum Innovations Eosinophilic Esophagitis Drug Sales by Product in 2024
5.7.6 Quorum Innovations Eosinophilic Esophagitis Drug Sales by Application in 2024
5.7.7 Quorum Innovations Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.7.8 Quorum Innovations Recent Developments
5.8 Takeda
5.8.1 Takeda Company Information
5.8.2 Takeda Description, Business Overview
5.8.3 Takeda Eosinophilic Esophagitis Drug Products Offered
5.8.4 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Takeda Eosinophilic Esophagitis Drug Sales by Product in 2024
5.8.6 Takeda Eosinophilic Esophagitis Drug Sales by Application in 2024
5.8.7 Takeda Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.8.8 Takeda Recent Developments
5.9 Calypso
5.9.1 Calypso Company Information
5.9.2 Calypso Description, Business Overview
5.9.3 Calypso Eosinophilic Esophagitis Drug Products Offered
5.9.4 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Calypso Eosinophilic Esophagitis Drug Sales by Product in 2024
5.9.6 Calypso Eosinophilic Esophagitis Drug Sales by Application in 2024
5.9.7 Calypso Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.9.8 Calypso Recent Developments
5.10 Celgene
5.10.1 Celgene Company Information
5.10.2 Celgene Description, Business Overview
5.10.3 Celgene Eosinophilic Esophagitis Drug Products Offered
5.10.4 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Celgene Eosinophilic Esophagitis Drug Sales by Product in 2024
5.10.6 Celgene Eosinophilic Esophagitis Drug Sales by Application in 2024
5.10.7 Celgene Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.10.8 Celgene Recent Developments
5.11 Regeneron
5.11.1 Regeneron Company Information
5.11.2 Regeneron Description, Business Overview
5.11.3 Regeneron Eosinophilic Esophagitis Drug Products Offered
5.11.4 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Regeneron Eosinophilic Esophagitis Drug Sales by Product in 2024
5.11.6 Regeneron Eosinophilic Esophagitis Drug Sales by Application in 2024
5.11.7 Regeneron Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.11.8 Regeneron Recent Developments
6 North America
6.1 North America Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
6.2 North America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
6.2.1 North America Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
6.2.2 North America Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
6.3 North America Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
6.4 North America Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
8.2 Europe Eosinophilic Esophagitis Drug Market Facts & Figures by Country
8.2.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
8.2.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
8.3 Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
8.4 Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
9.2 Latin America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
9.2.1 Latin America Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
9.2.2 Latin America Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
9.3 Latin America Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
9.4 Latin America Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Eosinophilic Esophagitis Drug Supply Chain Analysis
11.2 Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
11.3 Eosinophilic Esophagitis Drug Clients Analysis
11.4 Eosinophilic Esophagitis Drug Sales Channel and Sales Model Analysis
11.4.1 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Eosinophilic Esophagitis Drug Distributors
12 Eosinophilic Esophagitis Drug Market Dynamics
12.1 Eosinophilic Esophagitis Drug Industry Trends
12.2 Eosinophilic Esophagitis Drug Market Drivers
12.3 Eosinophilic Esophagitis Drug Market Challenges
12.4 Eosinophilic Esophagitis Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Eosinophilic Esophagitis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Market by Application
1.3.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Eosinophilic Esophagitis Drug Market Size Estimates and Forecasts
2.1.1 Global Eosinophilic Esophagitis Drug Revenue 2020-2031
2.1.2 Global Eosinophilic Esophagitis Drug Sales 2020-2031
2.2 Eosinophilic Esophagitis Drug Market Size by Region: 2024 Versus 2031
2.3 Eosinophilic Esophagitis Drug Sales by Region (2020-2031)
2.3.1 Global Eosinophilic Esophagitis Drug Sales by Region: 2020-2025
2.3.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2031)
2.4 Eosinophilic Esophagitis Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Eosinophilic Esophagitis Drug Revenue by Region: 2020-2025
2.4.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020-2031)
3.1.1.1 Global Eosinophilic Esophagitis Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2031)
3.1.2.1 Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2031)
3.1.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2020-2031)
3.1.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Eosinophilic Esophagitis Drug Sales by Application (2020-2031)
3.2.1.1 Global Eosinophilic Esophagitis Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2031)
3.2.2.1 Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2031)
3.2.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2020-2031)
3.2.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Budesonide of Eosinophilic Esophagitis Drug Revenue Market Share by Application
3.3.2 Fluticasone of Eosinophilic Esophagitis Drug Revenue Market Share by Application
3.3.3 Others of Eosinophilic Esophagitis Drug Revenue Market Share by Application
4 Global Eosinophilic Esophagitis Drug by Manufacturers
4.1 Global Top Eosinophilic Esophagitis Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Eosinophilic Esophagitis Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Eosinophilic Esophagitis Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Eosinophilic Esophagitis Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Product Type
4.5.1 Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
4.5.3 Manufacturers Eosinophilic Esophagitis Drug Product Type and Application
4.5.4 Budesonide Market Sales of Eosinophilic Esophagitis Drug by Manufacturer
4.5.5 Fluticasone Market Sales of Eosinophilic Esophagitis Drug by Manufacturer
4.5.6 Others Market Sales of Eosinophilic Esophagitis Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
5.1.4 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Eosinophilic Esophagitis Drug Sales by Product in 2024
5.1.6 AstraZeneca Eosinophilic Esophagitis Drug Sales by Application in 2024
5.1.7 AstraZeneca Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Eosinophilic Esophagitis Drug Products Offered
5.2.4 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Eosinophilic Esophagitis Drug Sales by Product in 2024
5.2.6 GSK Eosinophilic Esophagitis Drug Sales by Application in 2024
5.2.7 GSK Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Bayer
5.3.1 Bayer Company Information
5.3.2 Bayer Description, Business Overview
5.3.3 Bayer Eosinophilic Esophagitis Drug Products Offered
5.3.4 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bayer Eosinophilic Esophagitis Drug Sales by Product in 2024
5.3.6 Bayer Eosinophilic Esophagitis Drug Sales by Application in 2024
5.3.7 Bayer Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.3.8 Bayer Recent Developments
5.4 Adare Pharmaceuticals
5.4.1 Adare Pharmaceuticals Company Information
5.4.2 Adare Pharmaceuticals Description, Business Overview
5.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
5.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales by Product in 2024
5.4.6 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales by Application in 2024
5.4.7 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.4.8 Adare Pharmaceuticals Recent Developments
5.5 DBV Technologies
5.5.1 DBV Technologies Company Information
5.5.2 DBV Technologies Description, Business Overview
5.5.3 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
5.5.4 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 DBV Technologies Eosinophilic Esophagitis Drug Sales by Product in 2024
5.5.6 DBV Technologies Eosinophilic Esophagitis Drug Sales by Application in 2024
5.5.7 DBV Technologies Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.5.8 DBV Technologies Recent Developments
5.6 Dr. Falk Pharma
5.6.1 Dr. Falk Pharma Company Information
5.6.2 Dr. Falk Pharma Description, Business Overview
5.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
5.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales by Product in 2024
5.6.6 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales by Application in 2024
5.6.7 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.6.8 Dr. Falk Pharma Recent Developments
5.7 Quorum Innovations
5.7.1 Quorum Innovations Company Information
5.7.2 Quorum Innovations Description, Business Overview
5.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
5.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Quorum Innovations Eosinophilic Esophagitis Drug Sales by Product in 2024
5.7.6 Quorum Innovations Eosinophilic Esophagitis Drug Sales by Application in 2024
5.7.7 Quorum Innovations Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.7.8 Quorum Innovations Recent Developments
5.8 Takeda
5.8.1 Takeda Company Information
5.8.2 Takeda Description, Business Overview
5.8.3 Takeda Eosinophilic Esophagitis Drug Products Offered
5.8.4 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Takeda Eosinophilic Esophagitis Drug Sales by Product in 2024
5.8.6 Takeda Eosinophilic Esophagitis Drug Sales by Application in 2024
5.8.7 Takeda Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.8.8 Takeda Recent Developments
5.9 Calypso
5.9.1 Calypso Company Information
5.9.2 Calypso Description, Business Overview
5.9.3 Calypso Eosinophilic Esophagitis Drug Products Offered
5.9.4 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Calypso Eosinophilic Esophagitis Drug Sales by Product in 2024
5.9.6 Calypso Eosinophilic Esophagitis Drug Sales by Application in 2024
5.9.7 Calypso Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.9.8 Calypso Recent Developments
5.10 Celgene
5.10.1 Celgene Company Information
5.10.2 Celgene Description, Business Overview
5.10.3 Celgene Eosinophilic Esophagitis Drug Products Offered
5.10.4 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Celgene Eosinophilic Esophagitis Drug Sales by Product in 2024
5.10.6 Celgene Eosinophilic Esophagitis Drug Sales by Application in 2024
5.10.7 Celgene Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.10.8 Celgene Recent Developments
5.11 Regeneron
5.11.1 Regeneron Company Information
5.11.2 Regeneron Description, Business Overview
5.11.3 Regeneron Eosinophilic Esophagitis Drug Products Offered
5.11.4 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Regeneron Eosinophilic Esophagitis Drug Sales by Product in 2024
5.11.6 Regeneron Eosinophilic Esophagitis Drug Sales by Application in 2024
5.11.7 Regeneron Eosinophilic Esophagitis Drug Sales by Geographic Area in 2024
5.11.8 Regeneron Recent Developments
6 North America
6.1 North America Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
6.2 North America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
6.2.1 North America Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
6.2.2 North America Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
6.3 North America Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
6.4 North America Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
8.2 Europe Eosinophilic Esophagitis Drug Market Facts & Figures by Country
8.2.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
8.2.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
8.3 Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
8.4 Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
9.2 Latin America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
9.2.1 Latin America Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
9.2.2 Latin America Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
9.3 Latin America Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
9.4 Latin America Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Eosinophilic Esophagitis Drug Supply Chain Analysis
11.2 Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
11.3 Eosinophilic Esophagitis Drug Clients Analysis
11.4 Eosinophilic Esophagitis Drug Sales Channel and Sales Model Analysis
11.4.1 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Eosinophilic Esophagitis Drug Distributors
12 Eosinophilic Esophagitis Drug Market Dynamics
12.1 Eosinophilic Esophagitis Drug Industry Trends
12.2 Eosinophilic Esophagitis Drug Market Drivers
12.3 Eosinophilic Esophagitis Drug Market Challenges
12.4 Eosinophilic Esophagitis Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Eosinophilic Esophagitis Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Eosinophilic Esophagitis Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Eosinophilic Esophagitis Drug Sales by Region (2020-2025) & (K Units)
Table 5. Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Eosinophilic Esophagitis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Eosinophilic Esophagitis Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer (2020-2025)
Table 18. Eosinophilic Esophagitis Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Eosinophilic Esophagitis Drug Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
Table 24. Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
Table 26. Manufacturers Eosinophilic Esophagitis Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. AstraZeneca Company Information
Table 29. AstraZeneca Description and Business Overview
Table 30. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 31. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. AstraZeneca Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 33. AstraZeneca Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 34. AstraZeneca Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 35. AstraZeneca Recent Developments
Table 36. GSK Company Information
Table 37. GSK Description and Business Overview
Table 38. GSK Eosinophilic Esophagitis Drug Product
Table 39. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. GSK Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 41. GSK Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 42. GSK Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 43. GSK Recent Developments
Table 44. Bayer Company Information
Table 45. Bayer Description and Business Overview
Table 46. Bayer Eosinophilic Esophagitis Drug Product
Table 47. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Bayer Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 49. Bayer Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 50. Bayer Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 51. Bayer Recent Developments
Table 52. Adare Pharmaceuticals Company Information
Table 53. Adare Pharmaceuticals Description and Business Overview
Table 54. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 55. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Adare Pharmaceuticals Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 57. Adare Pharmaceuticals Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 58. Adare Pharmaceuticals Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 59. Adare Pharmaceuticals Recent Developments
Table 60. DBV Technologies Company Information
Table 61. DBV Technologies Description and Business Overview
Table 62. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 63. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. DBV Technologies Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 65. DBV Technologies Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 66. DBV Technologies Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 67. DBV Technologies Recent Developments
Table 68. Dr. Falk Pharma Company Information
Table 69. Dr. Falk Pharma Description and Business Overview
Table 70. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 71. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Dr. Falk Pharma Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 73. Dr. Falk Pharma Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 74. Dr. Falk Pharma Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 75. Dr. Falk Pharma Recent Developments
Table 76. Quorum Innovations Company Information
Table 77. Quorum Innovations Description and Business Overview
Table 78. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 79. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Quorum Innovations Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 81. Quorum Innovations Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 82. Quorum Innovations Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 83. Quorum Innovations Recent Developments
Table 84. Takeda Company Information
Table 85. Takeda Description and Business Overview
Table 86. Takeda Eosinophilic Esophagitis Drug Product
Table 87. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 89. Takeda Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 90. Takeda Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 91. Takeda Recent Developments
Table 92. Calypso Company Information
Table 93. Calypso Description and Business Overview
Table 94. Calypso Eosinophilic Esophagitis Drug Product
Table 95. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Calypso Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 97. Calypso Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 98. Calypso Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 99. Calypso Recent Developments
Table 100. Celgene Company Information
Table 101. Celgene Description and Business Overview
Table 102. Celgene Eosinophilic Esophagitis Drug Product
Table 103. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Celgene Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 105. Celgene Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 106. Celgene Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 107. Celgene Recent Developments
Table 108. Regeneron Company Information
Table 109. Regeneron Description and Business Overview
Table 110. Regeneron Eosinophilic Esophagitis Drug Product
Table 111. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Regeneron Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 113. Regeneron Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 114. Regeneron Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 115. Regeneron Recent Developments
Table 116. North America Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 117. North America Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 118. North America Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 121. North America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 122. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2020-2025) & (K Units)
Table 123. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2026-2031) & (K Units)
Table 124. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 127. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 128. Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 129. Europe Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 130. Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 133. Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 134. Latin America Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 135. Latin America Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 136. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 139. Latin America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 140. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 141. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 142. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 145. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 146. Eosinophilic Esophagitis Drug Key Raw Materials, Industry Status and Trend
Table 147. Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
Table 148. Eosinophilic Esophagitis Drug Clients Status and Trend
Table 149. Eosinophilic Esophagitis Drug Typical Clients
Table 150. Eosinophilic Esophagitis Drug Distributors
Table 151. Eosinophilic Esophagitis Drug Market Trends
Table 152. Eosinophilic Esophagitis Drug Market Drivers
Table 153. Eosinophilic Esophagitis Drug Market Challenges
Table 154. Eosinophilic Esophagitis Drug Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Product Picture
Figure 6. Others Product Picture
Figure 7. Global Eosinophilic Esophagitis Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Drugstore
Figure 12. Eosinophilic Esophagitis Drug Report Years Considered
Figure 13. Global Eosinophilic Esophagitis Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Eosinophilic Esophagitis Drug Market Size 2020-2031 (US$ Million)
Figure 15. Global Eosinophilic Esophagitis Drug Sales 2020-2031 (K Units)
Figure 16. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2031)
Figure 18. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 24. Budesonide of Eosinophilic Esophagitis Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Fluticasone of Eosinophilic Esophagitis Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Others of Eosinophilic Esophagitis Drug Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer in 2024
Figure 28. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Budesonide Market Sales Proportion by Manufacturer in 2024
Figure 30. Fluticasone Market Sales Proportion by Manufacturer in 2024
Figure 31. Others Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Eosinophilic Esophagitis Drug Revenue 2020-2031 (US$ Million)
Figure 33. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 34. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Eosinophilic Esophagitis Drug Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 40. Europe Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2031)
Figure 42. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2031)
Figure 43. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 44. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 45. Latin America Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 49. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 55. Eosinophilic Esophagitis Drug Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Eosinophilic Esophagitis Drug Raw Materials by Region in 2024
Figure 57. Eosinophilic Esophagitis Drug Distribution Channels
Figure 58. Global Eosinophilic Esophagitis Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Eosinophilic Esophagitis Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Eosinophilic Esophagitis Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Eosinophilic Esophagitis Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Eosinophilic Esophagitis Drug Sales by Region (2020-2025) & (K Units)
Table 5. Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Eosinophilic Esophagitis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Eosinophilic Esophagitis Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer (2020-2025)
Table 18. Eosinophilic Esophagitis Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Eosinophilic Esophagitis Drug Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
Table 24. Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
Table 26. Manufacturers Eosinophilic Esophagitis Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. AstraZeneca Company Information
Table 29. AstraZeneca Description and Business Overview
Table 30. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 31. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. AstraZeneca Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 33. AstraZeneca Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 34. AstraZeneca Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 35. AstraZeneca Recent Developments
Table 36. GSK Company Information
Table 37. GSK Description and Business Overview
Table 38. GSK Eosinophilic Esophagitis Drug Product
Table 39. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. GSK Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 41. GSK Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 42. GSK Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 43. GSK Recent Developments
Table 44. Bayer Company Information
Table 45. Bayer Description and Business Overview
Table 46. Bayer Eosinophilic Esophagitis Drug Product
Table 47. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Bayer Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 49. Bayer Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 50. Bayer Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 51. Bayer Recent Developments
Table 52. Adare Pharmaceuticals Company Information
Table 53. Adare Pharmaceuticals Description and Business Overview
Table 54. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 55. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Adare Pharmaceuticals Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 57. Adare Pharmaceuticals Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 58. Adare Pharmaceuticals Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 59. Adare Pharmaceuticals Recent Developments
Table 60. DBV Technologies Company Information
Table 61. DBV Technologies Description and Business Overview
Table 62. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 63. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. DBV Technologies Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 65. DBV Technologies Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 66. DBV Technologies Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 67. DBV Technologies Recent Developments
Table 68. Dr. Falk Pharma Company Information
Table 69. Dr. Falk Pharma Description and Business Overview
Table 70. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 71. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Dr. Falk Pharma Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 73. Dr. Falk Pharma Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 74. Dr. Falk Pharma Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 75. Dr. Falk Pharma Recent Developments
Table 76. Quorum Innovations Company Information
Table 77. Quorum Innovations Description and Business Overview
Table 78. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 79. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Quorum Innovations Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 81. Quorum Innovations Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 82. Quorum Innovations Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 83. Quorum Innovations Recent Developments
Table 84. Takeda Company Information
Table 85. Takeda Description and Business Overview
Table 86. Takeda Eosinophilic Esophagitis Drug Product
Table 87. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 89. Takeda Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 90. Takeda Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 91. Takeda Recent Developments
Table 92. Calypso Company Information
Table 93. Calypso Description and Business Overview
Table 94. Calypso Eosinophilic Esophagitis Drug Product
Table 95. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Calypso Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 97. Calypso Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 98. Calypso Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 99. Calypso Recent Developments
Table 100. Celgene Company Information
Table 101. Celgene Description and Business Overview
Table 102. Celgene Eosinophilic Esophagitis Drug Product
Table 103. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Celgene Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 105. Celgene Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 106. Celgene Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 107. Celgene Recent Developments
Table 108. Regeneron Company Information
Table 109. Regeneron Description and Business Overview
Table 110. Regeneron Eosinophilic Esophagitis Drug Product
Table 111. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Regeneron Sales Proportion of Eosinophilic Esophagitis Drug by Product in 2024
Table 113. Regeneron Sales Proportion of Eosinophilic Esophagitis Drug by Application in 2024
Table 114. Regeneron Sales Proportion of Eosinophilic Esophagitis Drug by Geographic Area in 2024
Table 115. Regeneron Recent Developments
Table 116. North America Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 117. North America Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 118. North America Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 121. North America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 122. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2020-2025) & (K Units)
Table 123. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2026-2031) & (K Units)
Table 124. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 127. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 128. Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 129. Europe Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 130. Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 133. Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 134. Latin America Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 135. Latin America Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 136. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 139. Latin America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 140. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 141. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2026-2031) & (K Units)
Table 142. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 145. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 146. Eosinophilic Esophagitis Drug Key Raw Materials, Industry Status and Trend
Table 147. Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
Table 148. Eosinophilic Esophagitis Drug Clients Status and Trend
Table 149. Eosinophilic Esophagitis Drug Typical Clients
Table 150. Eosinophilic Esophagitis Drug Distributors
Table 151. Eosinophilic Esophagitis Drug Market Trends
Table 152. Eosinophilic Esophagitis Drug Market Drivers
Table 153. Eosinophilic Esophagitis Drug Market Challenges
Table 154. Eosinophilic Esophagitis Drug Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Product Picture
Figure 6. Others Product Picture
Figure 7. Global Eosinophilic Esophagitis Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Drugstore
Figure 12. Eosinophilic Esophagitis Drug Report Years Considered
Figure 13. Global Eosinophilic Esophagitis Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Eosinophilic Esophagitis Drug Market Size 2020-2031 (US$ Million)
Figure 15. Global Eosinophilic Esophagitis Drug Sales 2020-2031 (K Units)
Figure 16. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2031)
Figure 18. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 24. Budesonide of Eosinophilic Esophagitis Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Fluticasone of Eosinophilic Esophagitis Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Others of Eosinophilic Esophagitis Drug Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer in 2024
Figure 28. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Budesonide Market Sales Proportion by Manufacturer in 2024
Figure 30. Fluticasone Market Sales Proportion by Manufacturer in 2024
Figure 31. Others Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Eosinophilic Esophagitis Drug Revenue 2020-2031 (US$ Million)
Figure 33. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 34. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Eosinophilic Esophagitis Drug Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 40. Europe Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2031)
Figure 42. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2031)
Figure 43. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 44. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 45. Latin America Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 49. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 55. Eosinophilic Esophagitis Drug Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Eosinophilic Esophagitis Drug Raw Materials by Region in 2024
Figure 57. Eosinophilic Esophagitis Drug Distribution Channels
Figure 58. Global Eosinophilic Esophagitis Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Eosinophilic Esophagitis Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232